These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 966987)

  • 21. [Immunological interactions in tumor growth].
    Saal F; Colmerauer ME; Rumi L; Pasqualini CD
    Sangre (Barc); 1973; 18(1):9-14. PubMed ID: 4708557
    [No Abstract]   [Full Text] [Related]  

  • 22. Depression of antilymphoma allograft reactivity by tumor-associated factors.
    Bonmassar E; Bonmassar A; Goldin A; Cudkowicz G
    Cancer Res; 1973 May; 33(5):1054-61. PubMed ID: 4703118
    [No Abstract]   [Full Text] [Related]  

  • 23. Leukemia virus-induced immunosuppression. X. Depression of T cell-mediated cytotoxicity after infection of mice with Friend leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1974 Jun; 112(6):2077-86. PubMed ID: 4207729
    [No Abstract]   [Full Text] [Related]  

  • 24. Lectin-induced nonlethal adhesions between cytolytic T lymphocytes and antigenically unrecognizable tumor cells and nonspecific "triggering" of cytolysis.
    Parker WL; Martz E
    J Immunol; 1980 Jan; 124(1):25-35. PubMed ID: 6765968
    [No Abstract]   [Full Text] [Related]  

  • 25. The immunogenic and tumorigenic properties of a murine lymphoma that expresses foreign alloantigens: role of helper factor(s) in generating a cytotoxic response in vitro.
    Scott JW; Finke JH
    Transplant Proc; 1981 Dec; 13(4):1867-73. PubMed ID: 6800082
    [No Abstract]   [Full Text] [Related]  

  • 26. Selective transformation of host lymphocytes in vivo by retrovirus-producing macrophages.
    Bosco MC; Musso T; Gusella GL; Giovarelli M; Forni M; Soleti A; Masuelli L; Modesti A; Forni G; Varesio L
    J Immunol; 1993 Jan; 150(1):278-89. PubMed ID: 8417128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxicity of vivo sensitized lymphocytes on allogeneic third-party fibroblasts differing for various regions of the H-2 complex.
    Jorgensen PN; Florentz K; Güttler F
    Transplant Proc; 1974 Mar; 6(1):95-9. PubMed ID: 4817057
    [No Abstract]   [Full Text] [Related]  

  • 28. Factors related to therapeutic efficacy in adoptive chemoimmunotherapy of a Friend virus-induced lymphoma.
    Fass L; Fefer A
    Cancer Res; 1972 Nov; 32(11):2427-31. PubMed ID: 5082591
    [No Abstract]   [Full Text] [Related]  

  • 29. Endotoxin-stimulated immune response to modified lymphoma cells.
    Prager MD; Ludden CM; Mandy WJ; Allison JP; Kitto GB
    J Natl Cancer Inst; 1975 Mar; 54(3):773-5. PubMed ID: 1168264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphological study of allogeneic tumor growth in mice bearing a glass cylinder.
    Filippa DA; Dosne Pasqualini C
    Medicina (B Aires); 1975; 35(1):29-36. PubMed ID: 1092950
    [No Abstract]   [Full Text] [Related]  

  • 31. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenic properties of mouse lymphoma cells.
    Hays EF
    J Immunol; 1968 Feb; 100(2):245-51. PubMed ID: 5639696
    [No Abstract]   [Full Text] [Related]  

  • 33. Combined effects of host antitumor immune responses and chemotherapy. Studies with hexamethylmelamine.
    Tricarico M; Fuschiotti P; Ricci F; De Filippi R; Nunziata C; Pastore S; De Vecchis L
    Chemioterapia; 1988 Jun; 7(3):203-7. PubMed ID: 3139307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specificity of cell-mediated transplantation reactions. I. Studies with the technique of inhibition of migration and an assay of tumour immunity in vivo.
    Lake P; Sabbadini E; Sehon AH
    Immunology; 1974 Sep; 27(3):427-39. PubMed ID: 4137936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigenic modulation as a mechanism for tumor escape from immune destruction: identification of modulation-positive and modulation-negative mouse lymphomas with xenoantisera to murine leukemia virus gp70.
    Stackpole CW; Cremona P; Leonard C; Stremmel P
    J Immunol; 1980 Oct; 125(4):1715-23. PubMed ID: 6251136
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) mice.
    Schirrmacher V
    Invasion Metastasis; 1981; 1(1):4-21. PubMed ID: 7188381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA transfer of immunity in murine allogeneic tumor model.
    Colmerauer ME; Laguens RP; Segal A; Pasqualini CD
    Medicina (B Aires); 1978; 38(6 Pt 1):643-6. PubMed ID: 374930
    [No Abstract]   [Full Text] [Related]  

  • 38. Induction of immune unresponsiveness by intrathymic injection of allogeneic cells in a murine model.
    Sherburne CG; Onyekaba CO; Condie RM
    Transplant Proc; 1993 Feb; 25(1 Pt 1):307-11. PubMed ID: 8438313
    [No Abstract]   [Full Text] [Related]  

  • 39. Is immunosuppression at the tumor site mechanism of evasion of a systemic response?
    Karakousis CP; Sharma S; Brooks SP
    J Med; 2003; 34(1-6):3-14. PubMed ID: 17682306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of "foreign" alloantigen-like specificities on a murine lymphoma cell line.
    Finke JH; Fyfe DA; Del Villano BC; Butler GH; Ponzio NM
    Transplant Proc; 1980 Mar; 12(1):53-8. PubMed ID: 6154359
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.